Guru Ownership Trend
Guru Analysis for TG Therapeutics, Inc. (TGTX)
TG Therapeutics, Inc. (TGTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $25.98 M.
Top institutional holders include Steven Cohen and Ray Dalio.
Institutional sentiment is currently Bullish. This is evidenced by a $3.65 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 103.3%. Conversely, Steven Cohen reduced exposure by 49.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for TG Therapeutics, Inc. (TGTX)
Major holders include Steven Cohen ($13.22 M), Ray Dalio ($12.36 M), Paul Tudor Jones ($2.75 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 913,206 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.65 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TGTX. The total reported sell value was $12.7 M.
Yes, 2 managers opened new positions in TGTX, and 1 increased their existing holdings. The total reported buy value was $16.35 M.
